Optic Nerve Head Strain in Non-glaucoma Subjects
NCT07425535 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-04-08
Summary
Persons who do not have glaucoma will have pictures taken of the optic nerve with a standard camera before and 2 weeks after starting to take a daily glaucoma eye drop to lower eye pressure. These data will be used to compare to the same procedure performed with glaucoma patients to study how glaucoma injures the eye.
Conditions
Interventions
- DRUG
-
Latanoprost (0.005%)
Participants take the eye drop daily for less than one month
Sponsors & Collaborators
-
National Eye Institute (NEI)
collaborator NIH - lead OTHER
Principal Investigators
-
Harry Quigley, MD · Johns Hopkins University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2028-03-01
- Completion
- 2028-03-31
More Related Trials
-
R&D of Non-invasive Innovative Intracranial Waves Monitoring System for Diagnostics and Treatment Monitoring of Patients with Normal Tension Glaucoma
NCT06443411 ·Status: ENROLLING_BY_INVITATION
-
Ocular Hypertension Treatment Study (OHTS)
NCT00000125 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Innovations in Glaucoma Study
NCT00221897 ·Status: RECRUITING
-
Optic Nerve Compliance Study
NCT00328835 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy
NCT03595865 ·Status: UNKNOWN ·Phase: NA
-
Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma
NCT04455126 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nailfold Capillary Blood Flow With Latanoprost Bunod
NCT03949244 ·Status: COMPLETED ·Phase: PHASE4
-
Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow
NCT01308788 ·Status: COMPLETED
-
Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
NCT00001161 ·Status: COMPLETED
-
Advanced Glaucoma Progression Study
NCT01742819 ·Status: ACTIVE_NOT_RECRUITING
-
Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure
NCT03689088 ·Status: COMPLETED ·Phase: NA
-
NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
NCT01408472 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
NCT07076303 ·Status: RECRUITING
-
Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study
NCT05030714 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of IOP Lowering on Progressive HM
NCT05850936 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure
NCT00706056 ·Status: COMPLETED
-
Are There Changes in the Nerve Fiber Layer (NFL) After Lowering of Eye Pressure?
NCT02600403 ·Status: COMPLETED
-
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
NCT03675412 ·Status: RECRUITING ·Phase: NA
-
Assessment of Effectiveness Ex-Press Surgery Modification
NCT03800589 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
NCT06953349 ·Status: RECRUITING
-
Ability of Patients With Low Vision to Properly Instill Eye Drops
NCT00760240 ·Status: COMPLETED
-
Does Oral Acetaminophen Lower Intraocular Pressure?
NCT02366065 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data
NCT01145898 ·Status: COMPLETED
-
Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
NCT00869141 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients
NCT03104621 ·Status: COMPLETED ·Phase: PHASE4